VXRT stock forecast 2025 refers to the predicted performance of the stock of Vaxart, Inc. (VXRT) in the year 2025. Stock forecasts attempt to predict the future price of a stock based on various factors such as the company’s financial performance, industry trends, and overall economic conditions.
VXRT is a clinical-stage biotechnology company focused on developing oral vaccines for infectious diseases. The company’s lead product candidate is VXA-CoV2-1, an oral vaccine for COVID-19. Vaxart has also developed oral vaccines for norovirus, seasonal influenza, and respiratory syncytial virus (RSV).
